🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "targeted steps to deal with household expense challenges" in the forthcoming financial statement.

During an interview with the BBC, she stated that reducing price rises is a joint duty of both the administration and the Bank of England.

The UK's price growth is projected to be the most elevated among the Group of Seven advanced economies this year and next.

Potential Energy Bill Interventions

Sources suggest the government could take action to bring down energy bills, for instance by cutting the current 5% level of VAT charged on energy.

A further possibility is to reduce some of the government charges presently included in bills.

Budgetary Constraints and Analyst Predictions

The administration will receive the latest draft from the official forecaster, the OBR, on the start of the week, which will reveal how much scope there is for these measures.

The view from the majority of experts is that Reeves will have to declare tax rises or expenditure reductions in order to meet her declared fiscal targets.

Earlier on the same day, analysis indicated there was a £22 billion deficit for the Treasury chief to address, which is at the lower end of projections.

"It is a shared responsibility between the Bank of England and the government to continue tackling some of the causes of price increases," Reeves informed the BBC in Washington, at the conferences of the IMF and global financial institution.

Revenue Commitments and Global Concerns

While a great deal of the focus has been on probable tax increases, the chancellor said the most recent data from the OBR had not changed her pledge to election pledges not to increase tax levels on income tax, sales tax or National Insurance.

She attributed an "uncertain world" with increasing geopolitical and commercial issues for the Budget tax moves, likely to be targeted on those "wealthiest."

Global Economic Disputes

Addressing worries about the UK's trade ties with China she said: "The UK's national security always take priority."

Recent announcement by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are crucial for high-technology production led American leader Donald Trump to propose an further 100% tariff on goods from the Asian country, raising the prospect of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary described the Chinese move "economic coercion" and "a global supply chain power grab."

Questioned on considering the US offer to participate in its conflict with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the move was "damaging for the world economy and causes additional obstacles."

"In my view there are areas where we must address China, but there are also important prospects to trade with Chinese markets, including financial services and other areas of the economic system. We've got to get that equilibrium appropriate."

The Treasury chief also confirmed she was collaborating with G7 counterparts "regarding our own essential resources strategy, so that we are reduced dependence."

Health Service Medicine Pricing and Investment

Reeves also recognized that the cost the National Health Service pays for medicines could increase as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in return for reduced taxes and investment.

Some of the biggest global drug companies have said recently that they are either halting or scrapping operations in the UK, with several blaming the insufficient payments they are getting.

Last month, the government science advisor said the cost the NHS spends on medicines would need to rise to halt firms and pharmaceutical investment leaving the UK.

The Chancellor stated to the BBC: "It has been observed as a result of the pricing regime, that clinical trials, innovative medicines have not been provided in the UK in the way that they are in other EU nations."

"Our aim is to make sure that patients getting care from the NHS are able to receive the finest critical medicines in the globe. And so we are reviewing these issues, and... seeking to secure additional capital into the UK."